Therapeutics News
-
Novartis expands its biopharmaceutical manufacturing site in Singapore
Therapeutics | Company results | 2 Comment | 15 Mar, 2024
Novartis is investing $256 million to expand its biopharmaceutical manufacturing plant in Singapore. The extended s...Read more
-
Zika virus vaccine emerges as tool in battling brain cancer: Singaporean study
Therapeutics | News | 0 Comment | 11 Mar, 2024
Scientists from Duke-NUS Medical School (Duke-NUS) at Singapore have developed a new approach using the Zika virus to de...Read more
-
Taiwan’s BioGate Precision Medicine Corp develops pancreatic cancer therapy
Therapeutics | News | 0 Comment | 07 Mar, 2024
Taiwan-based BioGate Precision Medicine Corp., a member of Powerchip Group, has unveiled an innovative breakthrough in p...Read more
-
First ever large-scale GMP manufacturing of therapeutic IgE antibody achieved in the UK
Therapeutics | News | 0 Comment | 05 Mar, 2024
Epsilogen, a leading immunoglobulin E (IgE) antibodies developer treating cancer, and global biopharma leader Lonza have...Read more
-
Novel platform can significantly reduces drug testing and screening time in cancer diagnosis
Therapeutics | News | 0 Comment | 04 Mar, 2024
In a breakthrough for personalised oncology, scientists from the National University of Singapore (NUS) and the National...Read more
-
Korea develops implant coating triggering antibiotic release against bacterial infection
Therapeutics | News | 0 Comment | 04 Mar, 2024
A collaborative research team from the Department of Chemical Engineering and the School of Convergence Science and Tech...Read more
-
Therapeutics | Opinion | By Ayesha Siddiqui | 0 Comment | 01 Mar, 2024
Could you give us an overview of the GHIT Fund's mission and how it originated? The idea for the GHIT (Global Health In...Read more
-
Korea using new rapid test for early outbreak control of Hantavirus
Therapeutics | News | 0 Comment | 01 Mar, 2024
Orthohantaviruses, highly transmissible zoonotic pathogens, are notorious for causing haemorrhagic fever with renal synd...Read more
-
Malaysia's trajectory in redefining Cancer Treatment Standards
Therapeutics | Analysis | 1 Comment | 22 Feb, 2024
As the world marks Cancer Awareness Month, Malaysia has made significant strides in the field of cancer treatment, earni...Read more
-
Daiichi Sankyo unveils APAC regional hub for RDPV QA operations in Singapore
Therapeutics | Company results | 2 Comment | 22 Feb, 2024
Daiichi Sankyo, an innovative global healthcare company, has launched its subsidiary Daiichi Sankyo Singapore ...Read more
-
Singapore approves AffaMed Therapeutics drug for Ocular Inflammation
Therapeutics | News | 0 Comment | 21 Feb, 2024
China's AffaMed Therapeutics, has obtained New Drug Application (NDA) from Singapore Health Sciences Authority (HSA...Read more
-
Australian govt injects $50 M to construct world-leading artificial heart
Therapeutics | News | 0 Comment | 20 Feb, 2024
The Australian government is providing $50 million to develop and commercialise the world’s most advanced artifici...Read more
-
Japan's Astellas Pharma inks oncology deal worth $800 M with US-based biotech startup Kelonia
Therapeutics | News | 0 Comment | 20 Feb, 2024
Japan headquartered Astellas Pharma and US-based biotech startup Kelonia Therapeutics have announced a collaborative eff...Read more
-
China develops potential new treatment for brain tumours and Parkinson’s disease
Therapeutics | News | 0 Comment | 15 Feb, 2024
A joint multi-disciplinary team from The Chinese University of Hong Kong (CUHK)’s Faculty of Medicine (CU Medicine...Read more
-
Latest insights on genetic testing related hearing loss
Therapeutics | Analysis | 1 Comment | 09 Feb, 2024
According to the World Health Organization (WHO), approximately 2.5 billion people worldwide are estimated to have some ...Read more
-
Korean startup C-Biomex announces oncology research partnership with US-based MD Anderson
Therapeutics | News | 0 Comment | 12 Feb, 2024
The University of Texas MD Anderson Cancer Center in the US, and South Korea-based startup C-Biomex have announced ...Read more
-
Australia's Recce partners Indonesia's Etana Biotech to advance anti-infective R&D, manufacturing
Therapeutics | News | 0 Comment | 08 Feb, 2024
Recce Pharmaceuticals Limited, the Company developing a New Class of Synthetic Anti-Infectives, has signed Memorand...Read more
-
Harnessing AI’s Potential for a Revolution in Cancer Screening
Therapeutics | Analysis | 3 Comment | 07 Feb, 2024
Imagine a world where a non-invasive breast cancer test delivers results within 15 minutes, costing less than half the p...Read more
